Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/29/2011US20110321193 Method And Compositions for the Production of Transgenic Plants
12/29/2011US20110321192 Tomato plants having higher levels of resistance to botrytis
12/29/2011US20110321191 Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants
12/29/2011US20110321190 Method of positive plant selection using sorbitol dehydrogenase
12/29/2011US20110321189 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/29/2011US20110321188 Solanum lycopersicum histidine decarboxylase gene-derived fruit-specific expression promoter and uses thereof
12/29/2011US20110321187 Plant plastid transformation method
12/29/2011US20110321186 Modulation of plant cell wall deposition via hdzipi
12/29/2011US20110321185 Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof
12/29/2011US20110321184 Plant with altered inflorescence
12/29/2011US20110319869 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
12/29/2011US20110319603 Method for fluorescently labeling protein
12/29/2011US20110319602 T2r taste receptors and genes encoding same
12/29/2011US20110319600 Human Anti-Human Influenza Virus Antibody
12/29/2011US20110319599 MN Gene and Protein
12/29/2011US20110319597 Variant domain antibodies
12/29/2011US20110319493 Histone deacetylases, and uses related thereto
12/29/2011US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
12/29/2011US20110319474 siRNA targeting cyclin-dependent kinase 4 (CDK4)
12/29/2011US20110319471 Lna antagonists targeting the androgen receptor
12/29/2011US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011US20110319336 Selective anticancer chimeric peptide
12/29/2011US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011US20110319297 siRNA targeting gremlin
12/29/2011US20110319296 siRNA targeting histamine receptor H1
12/29/2011US20110319294 Stable, functional chimeric cellobiohydrolase class i enzymes
12/29/2011US20110319291 Template fixed beta-hairpin loop mimetics and their use in phage display
12/29/2011US20110318838 CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY
12/29/2011US20110318834 Multiple-tumor aberrant growth genes
12/29/2011US20110318832 Human Telomerase Catalytic Subunit
12/29/2011US20110318827 Cysteine-Free Efficient Technetium (Tc) or Rhenium (Re) Chelating Peptide Tags and Their Use
12/29/2011US20110318826 Inotropic antibodies and therapeutic uses thereof
12/29/2011US20110318810 Flavin-binding glucose dehydrogenases
12/29/2011US20110318808 Engineered Plant Cysteine Proteases and Their Uses
12/29/2011US20110318806 Site specific incorporation of keto amino acids into proteins
12/29/2011US20110318801 Xylose utilization in recombinant zymomonas
12/29/2011US20110318797 Cytochrome P450s and uses thereof
12/29/2011US20110318786 Dna polymerases with increased 3'-mismatch discrimination
12/29/2011US20110318779 Process for producing recombinant protein using novel fusion partner
12/29/2011US20110318758 Human monoclonal antibodies and methods for producing the same
12/29/2011US20110318430 Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
12/29/2011US20110318389 Human pancreatic beta cell lines for diagnostic of diabetes
12/29/2011US20110318384 Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same
12/29/2011US20110318379 Vaccine for Porcine Post-Weaning Diarrhea Caused by Enterotoxigenic Escherichia Coli
12/29/2011US20110318378 Peptides Presenting an Epitope of a Domain of Factor H Binding Protein and Methods of Use
12/29/2011US20110318376 Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
12/29/2011US20110318374 Spanx-b polypeptides and their use
12/29/2011US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011US20110318369 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2011US20110318363 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011US20110318362 Novel card proteins involved in cell death regulation
12/29/2011US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4
12/29/2011US20110318357 Methods and compositions based on shiga toxin type 2 protein
12/29/2011US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011US20110318353 Humanized IL-25 Antibodies
12/29/2011US20110318349 Dual variable domain immunoglobulins and uses thereof
12/29/2011US20110318339 Anti-dll4 antibodies and uses thereof
12/29/2011US20110318318 Anti-apoptotic fusion proteins
12/29/2011US20110318317 Chinese hamster apoptosis-related genes
12/29/2011US20110318316 Chinese hamster apoptosis-related genes
12/29/2011US20110318312 Rejuvenation or preservation of germ cells
12/29/2011US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011US20110318268 Herpes simplex virus (hsv) with modified tropism, uses and process of preparation thereof
12/29/2011DE102010030609A1 Neue Proteasen und diese enthaltende Mittel New proteases and compositions comprising them
12/29/2011CA2804925A1 Acyltransferases and uses therof in fatty acid production
12/29/2011CA2804879A1 Novel glycosyl hydrolase with beta-xylosidase and beta-glucosidase activities and uses thereof
12/29/2011CA2804311A1 Mice expressing alight chain with human lambda variable and mouse constant regions
12/29/2011CA2803882A1 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
12/29/2011CA2803868A1 Plants with altered levels of vegetative starch
12/29/2011CA2803864A1 Mice expressing an immunoglobulin hybrid light chain
12/29/2011CA2803599A1 Accumulation of omega-7 fatty acids in plant seeds
12/29/2011CA2803392A1 Dual variable domain immunoglobulins and uses thereof
12/29/2011CA2803391A1 Colon and pancreas cancer specific antigens and antibodies
12/29/2011CA2803343A1 Aspergillus aculeatus derived polypeptides having c4-dicarboxylic acid transporter activity and polynucleotides encoding same
12/29/2011CA2803102A1 Methyltransferase nucleic acids and polypeptides
12/29/2011CA2803098A1 Lowering saturated fatty acid content of plant seeds
12/29/2011CA2803029A1 Constrained immunogenic compositions and uses therefor
12/29/2011CA2802946A1 Method and device
12/29/2011CA2802919A1 Genetic markers associated with intellectual disability
12/29/2011CA2802738A1 Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression
12/29/2011CA2801928A1 Double stranded rna compounds to rhoa and use thereof
12/29/2011CA2801688A1 Plants with enhanced yield-related traits and producing method thereof
12/29/2011CA2801422A1 Plants having enhanced yield-related traits and method for making the same
12/29/2011CA2801348A1 Methods for agrobacterium-mediated transformation of sugar cane
12/29/2011CA2799970A1 Compositions and methods for enhancing resistance to northern leaf blight in maize
12/28/2011EP2400024A1 Process for producing useful substance
12/28/2011EP2400023A1 A non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
12/28/2011EP2400022A1 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
12/28/2011EP2400021A2 ErbB3 based methods and compositions for treating neoplasms
12/28/2011EP2400020A1 Human micrornas and methods for inhibiting same
12/28/2011EP2400019A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400018A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400017A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400016A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400015A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400014A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400013A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400012A2 In tumours differentially expressed gene products and use of the same
12/28/2011EP2400011A2 In tumours differentially expressed gene products and use of the same